Temozolomide in Treating Young Patients With Refractory or Recurrent Leukemia

NCT00083070 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

16

Enrollment

NETWORK

Sponsor class

Conditions

Leukemia

Interventions

DRUG: temozolomide

Sponsor

Children's Oncology Group

Collaborators

[object Object]